These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

210 related items for PubMed ID: 34261897

  • 1. Managing abnormal liver tests in children with inflammatory bowel disease.
    van Rheenen PF.
    Curr Opin Pediatr; 2021 Oct 01; 33(5):521-529. PubMed ID: 34261897
    [Abstract] [Full Text] [Related]

  • 2. Clinical Presentation and Outcomes of Autoimmune Hepatitis in Inflammatory Bowel Disease.
    DeFilippis EM, Kumar S.
    Dig Dis Sci; 2015 Oct 01; 60(10):2873-80. PubMed ID: 25999245
    [Abstract] [Full Text] [Related]

  • 3. Hepatic Complications of Inflammatory Bowel Disease.
    Mahfouz M, Martin P, Carrion AF.
    Clin Liver Dis; 2019 May 01; 23(2):191-208. PubMed ID: 30947871
    [Abstract] [Full Text] [Related]

  • 4. Hepatobiliary manifestations in inflammatory bowel disease: the gut, the drugs and the liver.
    Rojas-Feria M, Castro M, Suárez E, Ampuero J, Romero-Gómez M.
    World J Gastroenterol; 2013 Nov 14; 19(42):7327-40. PubMed ID: 24259964
    [Abstract] [Full Text] [Related]

  • 5. Characteristics and outcome of primary sclerosing cholangitis associated with inflammatory bowel disease in Asian children.
    Lee WS, Karthik SV, Ng RT, Ong SY, Ong C, Chiou FK, Wong SY, Quak SH, Aw MM.
    Pediatr Neonatol; 2019 Aug 14; 60(4):396-404. PubMed ID: 31409456
    [Abstract] [Full Text] [Related]

  • 6. Autoimmune sequential overlap syndrome (autoimmune hepatitis/primary sclerosing cholangitis) and inflammatory bowel disease: three clinical cases.
    Núñez Figueroa P, Sedano Muñoz R, Quera Pino R, Carrasco-Avino G, O Brien A, Brahm Barril J.
    Rev Esp Enferm Dig; 2020 Oct 14; 112(10):788-791. PubMed ID: 32954772
    [Abstract] [Full Text] [Related]

  • 7. Use of IBD Drugs in Patients With Hepatobiliary Comorbidities: Tips and Tricks.
    Massironi S, Pirola L, Mulinacci G, Ciaccio A, Viganò C, Palermo A, Zilli A, Invernizzi P, Danese S.
    Inflamm Bowel Dis; 2023 Sep 01; 29(9):1477-1487. PubMed ID: 36040402
    [Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Autoimmune Hepatitis, Sclerosing Cholangitis, and Autoimmune Sclerosing Cholangitis or Overlap Syndrome.
    Kerkar N, Chan A.
    Clin Liver Dis; 2018 Nov 01; 22(4):689-702. PubMed ID: 30266157
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Immune-mediated diseases in primary sclerosing cholangitis.
    Lamberts LE, Janse M, Haagsma EB, van den Berg AP, Weersma RK.
    Dig Liver Dis; 2011 Oct 01; 43(10):802-6. PubMed ID: 21700515
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Risk factors for abnormal liver function tests in patients with ileal pouch-anal anastomosis for underlying inflammatory bowel disease.
    Navaneethan U, Remzi FH, Nutter B, Fazio VW, Shen B.
    Am J Gastroenterol; 2009 Oct 01; 104(10):2467-75. PubMed ID: 19550410
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 11.